Physicians Realty Trust’s (DOC) Buy Rating Reaffirmed at BMO Capital Markets

BMO Capital Markets reissued their buy rating on shares of Physicians Realty Trust (NYSE:DOC) in a research note released on Monday. They currently have a $18.00 price target on the real estate investment trust’s stock.

Several other research firms have also recently weighed in on DOC. Robert W. Baird reaffirmed an outperform rating and set a $19.00 price objective (down from $21.00) on shares of Physicians Realty Trust in a research report on Friday, January 5th. SunTrust Banks set a $18.00 price objective on Physicians Realty Trust and gave the company a hold rating in a research report on Monday, January 22nd. Zacks Investment Research cut Physicians Realty Trust from a hold rating to a sell rating in a research report on Tuesday, January 30th. Morgan Stanley cut their price objective on Physicians Realty Trust from $18.00 to $16.50 and set an equal weight rating on the stock in a research report on Tuesday, March 20th. Finally, Bank of America cut their price objective on Physicians Realty Trust from $19.50 to $18.00 and set a buy rating on the stock in a research report on Thursday, March 8th. Six research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus price target of $18.11.

How to Become a New Pot Stock Millionaire

Physicians Realty Trust stock opened at $15.06 on Monday. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.58. The company has a market cap of $2,695.48, a price-to-earnings ratio of 14.12, a PEG ratio of 3.08 and a beta of 0.45. Physicians Realty Trust has a fifty-two week low of $14.13 and a fifty-two week high of $21.85.

Physicians Realty Trust (NYSE:DOC) last posted its quarterly earnings data on Wednesday, February 28th. The real estate investment trust reported $0.27 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.27. The business had revenue of $97.30 million for the quarter, compared to analysts’ expectations of $98.56 million. Physicians Realty Trust had a return on equity of 1.63% and a net margin of 11.04%. The business’s revenue was up 32.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.27 EPS. analysts forecast that Physicians Realty Trust will post 1.12 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 18th. Stockholders of record on Tuesday, April 3rd will be given a $0.23 dividend. The ex-dividend date of this dividend is Monday, April 2nd. This represents a $0.92 dividend on an annualized basis and a dividend yield of 6.11%. Physicians Realty Trust’s dividend payout ratio is currently 88.46%.

In related news, Director Tommy G. Thompson purchased 13,650 shares of the company’s stock in a transaction dated Tuesday, March 6th. The shares were purchased at an average cost of $14.71 per share, with a total value of $200,791.50. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.53% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Nisa Investment Advisors LLC raised its holdings in Physicians Realty Trust by 355.1% in the 4th quarter. Nisa Investment Advisors LLC now owns 6,280 shares of the real estate investment trust’s stock worth $113,000 after acquiring an additional 4,900 shares during the last quarter. Cypress Wealth Services LLC purchased a new position in Physicians Realty Trust in the 4th quarter worth approximately $180,000. Greenwood Capital Associates LLC purchased a new position in Physicians Realty Trust in the 4th quarter worth approximately $194,000. Zeke Capital Advisors LLC purchased a new position in Physicians Realty Trust in the 4th quarter worth approximately $209,000. Finally, Xact Kapitalforvaltning AB purchased a new position in Physicians Realty Trust in the 4th quarter worth approximately $262,000. Institutional investors own 94.10% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Physicians Realty Trust’s (DOC) Buy Rating Reaffirmed at BMO Capital Markets” was first posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.chaffeybreeze.com/2018/04/17/physicians-realty-trusts-doc-buy-rating-reaffirmed-at-bmo-capital-markets.html.

About Physicians Realty Trust

Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare.

Analyst Recommendations for Physicians Realty Trust (NYSE:DOC)

Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply